Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
An Expert Opinion Regarding the Management of Lower Gastrointestinal Cancers During Covid-19 Outbreak in Iran: A Brief Report Publisher



Miri SR1 ; Mahmoodzadeh H2 ; Hadjilooei F3 ; Farahani PK4 ; Moradi M5 ; Alemrajabi M5 ; Memari F1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Breast Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Radiation Oncology, University of Toronto, Toronto, Canada
  4. 4. Department of General Surgery, Alborz University of Medical Sciences, Karaj, Iran
  5. 5. Firoozgar Development Research Center (FDRC), Iran University of Medical Sciences, Tehran, Iran

Source: Acta Medica Iranica Published:2021


Abstract

Lower gastrointestinal cancer patients, like other immunosuppressed patients, are vulnerable to develop more severe infections. Iran is one of the countries with a high incidence of COVID-19, and some modifications are needed to adjust international protocols to deal with this pandemic. Therefore, our cancer institute has implemented some changes in the current treatment guidelines. In each specialty, all members agreed to choose the minimal intervention. The members know that some recommendations may interfere with the routine best-practice recommendations and decrease the quality measures in the patient's outcome. Therefore, these recommendations are valid just in the epidemic COVID-19 situation in the country. According to the consensus of colorectal and cancer surgery professors, if a patient is a new case of rectal cancer, he or she should be referred to undergo neoadjuvant chemoradiotherapy. But if the patient comes eight to twelve weeks after receiving chemoradiotherapy in accordance with the COVID-19 epidemic phase, it may be possible to delay surgery. A stent can be implanted in a patient with rectal cancer who presents with obstructive symptoms, and surgery can be postponed until resolving the crisis of the COVID-19 epidemic or its downward trend. For colon cancer, we will request a thoracic spiral CT scan. If there was no evidence of pulmonary involvement with COVID-19, the patient would undergo open surgery considering the patient's health and protection tips. © 2021 Tehran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Cancer and Coronavirus Disease (Covid-19): Comorbidity, Mechanical Ventilation, and Death Risk, Journal of Gastrointestinal Cancer (2021)
2. Non-Communicable Diseases and Covid-19; a Double-Edged Sword A Special Communication From Iran, Journal of Diabetes and Metabolic Disorders (2020)
3. Factors Associated With Covid-19 Morbidity and Mortality: A Narrative Review, Journal of Iranian Medical Council (2020)
4. A Meta-Analysis for Prevalence of Lung Cancer Patients With Sars-Cov-2 Infection During the Covid-19 Pandemic, Eurasian Journal of Medicine and Oncology (2022)
5. A Review on an Ongoing Pandemic Caused by the Severe Acute Respiratory Syndrome Coronavirus 2: The Pathogenesis, Epidemiology, Immunological Features, and Currently Available Diagnostic Tests, Reviews and Research in Medical Microbiology (2022)
6. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
7. Recommendations for Breast Surgical Care During Covid-19 Outbreak in Iran: Setting Priorities of Management, World Cancer Research Journal (2020)
8. Cancer and Covid-19: The Synergistic Burden on Mental Health Status of Patients With Cancer, Middle East Journal of Cancer (2022)
Experts (# of related papers)
View all Related Experts
Soroush Rad (3)
Farhad Shahi (2)
Other Related Docs
9. Mortality Risk Factors Among Hospitalized Covid-19 Patients in a Major Referral Center in Iran, Tohoku Journal of Experimental Medicine (2020)
10. The Comparison of Clinical, Laboratory, and Radiological Findings in Immunocompromised and Immunocompetent Patients With Covid-19: A Case-Control Study, Immunity# Inflammation and Disease (2023)
11. How Prevalent Is Cancer in Confirmed Cases With Coronaviruses and Severe Acute Respiratory Syndromes?, Advances in Experimental Medicine and Biology (2021)
12. Factors Associated With Mortality in Covid-19 Patients: A Systematic Review and Meta-Analysis, Iranian Journal of Public Health (2020)
13. Management of Patients With Liver Transplant and Chronic Liver Diseases During Covid-19 Pandemic: A Brief Review, Archives of Iranian Medicine (2020)
14. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
15. Management Policies of Breast Cancer Surgery, Chemotherapy and Radiotherapy During Covid-19 Outbreak in Iran, World Cancer Research Journal (2020)
16. Challenges Posed by Covid-19 in Cancer Patients: A Narrative Review, Cancer Medicine (2022)
17. Covid-19-Related Mortality in Kidney Transplant and Dialysis Patients: Results of the Eracoda Collaboration, Nephrology Dialysis Transplantation (2020)
18. Clinical Characteristics, Outcomes, and Risk Factors for Mortality in Hospitalized Patients With Covid-19 and Cancer History: A Propensity Score-Matched Study, Infectious Agents and Cancer (2020)
19. Routine Covid-19 Testing May Not Be Necessary for Most Cancer Patients, Scientific Reports (2021)
20. Covid-19 and Cancer: A Comparative Case Series, Cancer Treatment and Research Communications (2021)
21. Computed Tomography Scan in Covid-19: A Systematic Review and Meta-Analysis, Polish Journal of Radiology (2022)
22. Modifications in Breast Cancer Guidelines in Covid-19 Pandemic; an Iranian Consensus, Archives of Breast Cancer (2020)
23. Chest-Ct Findings of Covid-19 in Patients With Pre-Existing Malignancies; a Pictorial Review, Clinical Imaging (2020)